Pulmonary Emphysema Clinical Trial
Official title:
Phase 1 Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Heterogeneous Emphysema
The purpose of this study is to determine whether the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System is safe in patients with advanced emphysema.
Patients with emphysema currently have limited treatment choices. Many patients are treated
with steroids and inhaled medications, which often provide little or no benefit. Recently,
lung volume reduction surgery has become an accepted therapy for emphysema. Lung volume
reduction surgery involves the removal of a diseased portion of the lung, which enables the
remaining, healthier portions of the lung to function better. This procedure, although
effective, is complicated and risky.
Aeris Therapeutics has developed the Aeris Bronchoscopic Lung Volume Reduction System for
treatment of patients with advanced emphysema. The Aeris BLVR System is designed to reduce
lung volume without surgery. Patients are treated under anesthesia using a bronchoscope to
direct treatment to the most damaged areas of the lung. The treatment is expected to reduce
lung volume by shrinking the diseased areas of the lung. The purpose of the current study is
to find out whether the Aeris BLVR System is safe in patients with advanced emphysema. The
risks associated with the treatment are expected to be similar to those associated with
general anesthesia and bronchoscopy.
;
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00995852 -
Unilateral Versus Bilateral Endoscopic Lung Volume Reduction A Comparative Case Study
|
Phase 2/Phase 3 | |
Completed |
NCT01860898 -
A Phase I Study of iPS Cell Generation From Patients With COPD
|
N/A | |
Completed |
NCT00123422 -
Innovation in Pulmonary Rehabilitation
|
N/A | |
Recruiting |
NCT02879331 -
Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils
|
N/A | |
Completed |
NCT01507415 -
Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?
|
N/A | |
Completed |
NCT01051258 -
AeriSeal System for Lung Volume Reduction
|
Phase 1/Phase 2 | |
Completed |
NCT00680056 -
Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients
|
Phase 4 | |
Completed |
NCT01872624 -
Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema
|
N/A | |
Completed |
NCT01110252 -
Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT00517998 -
Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
|
Phase 1 | |
Terminated |
NCT00205920 -
Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation
|
Phase 2 | |
Withdrawn |
NCT01849159 -
Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema
|
Phase 1/Phase 2 | |
Completed |
NCT01869205 -
The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema Patients
|
Phase 3 | |
Terminated |
NCT01320566 -
A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema
|
Phase 2/Phase 3 | |
Completed |
NCT00683722 -
PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Active, not recruiting |
NCT04465461 -
Video Assisted Thoracic Surgery (VATS) Fissure Completion Prior to Zephyr® Endobronchial Valve Insertion
|
N/A | |
Completed |
NCT04012359 -
Description of Bullous Emphysema Using Lung Ultrasound and Comparison to the Characteristics of Pneumothorax
|
||
Recruiting |
NCT04918706 -
Allogeneic MSC Treatment for Pulmonary Emphysema
|
Phase 2 | |
Terminated |
NCT01449292 -
Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
|
Phase 3 | |
Completed |
NCT00347659 -
US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study
|
Phase 1 |